While three medications for opioid abuse are approved by the Food and Drug Administration, the treatments are used sparingly in therapy according to a new review of data. . . . → Read More: Opioid Abuse Treatment Medications Underused
|
|||||
|
|
A grant from National Institutes of Health is funding a system using augmented reality and holography to improve minimally-invasive repair of blood vessels. . . . → Read More: NIH Funds Augmented-Reality Endovascular System 
A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations  One comment - (Comments are closed)  Regulations  biomedical, biotechnology, FDA, genomics, life sciences, pharmaceuticals, standard 
A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial One comment - (Comments are closed) New products, Regulations biomedical, biotechnology, clinical trials, Europe, FDA, life sciences, pharmaceuticals, preclinical 
The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, genomics, life sciences, pharmaceuticals, preclinical 
A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver drugs or cosmetics through the skin. . . . → Read More: Energy-Efficient Process Devised for Nano-Emulsions One comment - (Comments are closed) Joint ventures/collaborations, New products biomedical, chemistry, Europe, FDA, life sciences, materials science, nanotechnology, pharmaceuticals, physical sciences, university 
A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy. . . . → Read More: Synthetic Cannabidiol Shown to Reduce Seizures One comment - (Comments are closed) New products biomedical, chemistry, entrepreneurs, FDA, life sciences, patent, pharmaceuticals, physical sciences, preclinical, U.K., university 
The Food and Drug Administration authorized a wearable nerve-stimulation device controlled by a mobile app to treat acute migraine headaches. . . . → Read More: FDA Clears Wearable App Device for Migraine Comments are closed Regulations biomedical, clinical trials, engineering, entrepreneurs, FDA, Israel, life sciences, medical device, physical sciences, software 
The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one. . . . → Read More: FDA Approves Rare Infant Disease Gene Therapy Comments are closed Regulations biomedical, biotechnology, clinical trials, economics, Europe, FDA, genomics, life sciences, pharmaceuticals
Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days. . . . → Read More: Trial Shows Surgical Pain Managed Without Opioids Comments are closed Regulations biomedical, biotechnology, clinical trials, FDA, life sciences, pharmaceuticals |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||